Sakura N, Usui T, Ito K, Ha K S, Ikeda T, Yabuuchi H, Iwanami N, Komiyama A, Akabane T
Eur J Pediatr. 1981 Oct;137(2):207-10. doi: 10.1007/BF00441319.
In a second and third families with ADA deficiency found in Japan, we tried a new approach to evaluate heterozygote detection. This is based on the hypothesis that ADA activity of red blood cell is the quantitative sum of the activities of ADA proteins expressed by two allelic genes at the ADA autosomal locus, and that these activities are not changed by the gene transmission from parents to children. We have detected red blood cell-ADA activities expressed by the one normal allelic gene in heterozygotes (including parents and paternal or maternal grandfather or grandmother) and from these values have determined combinations for the pair of ADA activities expressed by the two allelic genes of other family members. These combinations were consistently made in all relatives examined in the two families, and we conclude that several members of each family who were judged to have nil activity in the combinations were heterozygotes for ADA deficiency.
在日本发现的另外两个患有腺苷脱氨酶(ADA)缺乏症的家族中,我们尝试了一种新方法来评估杂合子检测。这基于以下假设:红细胞的ADA活性是ADA常染色体位点上两个等位基因所表达的ADA蛋白活性的定量总和,并且这些活性不会因基因从父母传递给子女而改变。我们检测了杂合子(包括父母以及父系或母系的祖父或祖母)中由一个正常等位基因所表达的红细胞ADA活性,并根据这些值确定了其他家庭成员两个等位基因所表达的ADA活性对的组合。在这两个家族中接受检查的所有亲属中,这些组合始终一致,我们得出结论,在组合中被判定为无活性的每个家族的几名成员是ADA缺乏症的杂合子。